retatrutide phase 2 results 2024 2025 III study demonstrates 30% weight loss Efficacy and Safety of GLP‐1

Advanced ultrasound skin tightening in Glasgow that stimulates collagen, lifts lax skin and improves firmness, while preserving natural facial volume and expression over time

When you're already dealing with reduced appetite from GLP-1s, this might seem counterintuitive

If youve shaken it vigorously, the integrity of the solution is likely compromised and it should not be used for accurate research

In the STEP 1 semaglutide trial (Wilding et al., NEJM , 2021) and the SURMOUNT-1 tirzepatide trial (Jastreboff et al., NEJM , 2022), nausea affected roughly 44% of semaglutide patients and about 24% of tirzepatide patients at the maximum dose

KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease